InChI
1S/C8H8.C5H8O2/c1-2-8-6-4-3-5-7-8;1-4(2)5(6)7-3/h2-7H,1H2;1H2,2-3H3
InChI key
ADFPJHOAARPYLP-UHFFFAOYSA-N
form
solid
mol wt
average Mn 25,000 (PMMA), average Mn 57,000 (polystyrene), average Mn 82,000
transition temp
Tm 350-355 °C
Mw/Mn
<1.2
正在寻找类似产品? 访问 产品对比指南
General description
52 kDa PS; 52 kDa PMMA; m ~542; n ~250
PS Mn = 52 ± 5 kg/mol
PMMA Mn = 52 ± 5 kg/mol
整个嵌段共聚物<1.2的PDI
通过SEC（从反应混合物中取等分试样）验证的PS分子量和通过NMR光谱法得到的PMMA分子量。整个嵌段共聚物分子量分布将通过SEC进行测定。
PS Mn = 52 ± 5 kg/mol
PMMA Mn = 52 ± 5 kg/mol
整个嵌段共聚物<1.2的PDI
通过SEC（从反应混合物中取等分试样）验证的PS分子量和通过NMR光谱法得到的PMMA分子量。整个嵌段共聚物分子量分布将通过SEC进行测定。
signalword
Warning
hcodes
pcodes
Hazard Classifications
Eye Irrit. 2
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Takeshi Ueki et al.
The journal of physical chemistry. B, 111(18), 4750-4754 (2007-02-27)
The solubility and phase behavior of poly(benzyl methacrylate) (PBzMA) and poly(styrene-co-methyl methacrylate) (P(St-co-MMA)) in a hydrophobic ionic liquid, 1-ethyl-3-methylimidazolium bis(trifluoromethane sulfone)imide ([C(2)mim][NTf(2)]), have been explored as a function of temperature. Although both polymers have solvatophobic phenyl groups and solvatophilic methacrylate
MN: Surgical LPN files product liability suit: cement Mfgr.'s failure to warn of health hazard.
Nursing law's Regan report, 42(8), 3-3 (2004-08-11)
S M Belkoff et al.
Bone, 25(2 Suppl), 23S-26S (1999-08-24)
The purpose of this study was to determine the strength and stiffness of osteoporotic vertebral bodies (VBs) subjected to compression fractures and subsequently treated with bipedicular injections of various polymethylmethacrylate cements. Ten spines were harvested from nonembalmed female cadavers (age
Polymethylmethacrylate: from polymer to dialyzer.
H Sugaya et al.
Contributions to nephrology, 125, 1-8 (1999-01-23)
M E Forsythe et al.
Journal of orthopaedic surgery (Hong Kong), 14(1), 38-42 (2006-04-07)
To compare the pharmacokinetic profile of tobramycin in blood, urine, and at the operative site following the use of Simplex-tobramycin bone cement in primary total hip replacement between patients with and without renal dysfunction. Six patients with renal dysfunction underwent
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持